Cheese Consumption and Human Microvascular Function
2 other identifiers
interventional
13
1 country
1
Brief Summary
Increased dairy intake is associated with improved measures of blood vessel health. Dairy cheese, however, is often high in sodium. Dietary sodium can impair blood vessel function. The researchers examine if and how natural cheese may protect against impairments in blood vessel function caused by sodium. For this study, participants complete four 8-day controlled feeding periods in which they eat cheese (6 oz/day) or no cheese during a low-sodium or high-sodium base-diet. The participants complete baseline experiments while on their normal personal diet and then repeat experiments at the end of each controlled feeding period. In some of our experiments, the researchers use a technique called "microdialysis" (MD). With MD, the researchers perfuse some research drugs into the skin on the forearm through tiny tubing that mimics capillaries. These MD drugs mimic or block substances the body naturally makes to control the small blood vessels in the skin. The drugs remain in nickel-sized areas around the tubing and do not go into the rest of the body. The researchers also use a standard technique called "flow mediated dilation" (FMD) that uses blood pressure cuffs and ultrasound to look at the health of larger blood vessels in the body. FMD includes placing a small tablet of nitroglycerin under the tongue during part of the test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Jul 2017
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 13, 2017
CompletedFirst Posted
Study publicly available on registry
December 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedResults Posted
Study results publicly available
May 4, 2025
CompletedMay 4, 2025
May 1, 2025
3.7 years
December 13, 2017
May 17, 2022
May 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microvascular Reactivity to Acetylcholine
Skin blood flow is measured with laser Doppler flowmetry (flux units) and normalized to cutaneous vascular conductance by dividing by mean arterial pressure. Log molar increasing concentrations of acetylcholine are perfused and dose response curves are generated. Dose response curves were analyzed to determine the logEC50 (log Molar)
1 hour
Secondary Outcomes (3)
Systolic Blood Pressure
8 days
Diastolic Blood Pressure
8 days
Flow Mediated Dilation
8 days
Study Arms (1)
Impact of Dairy and Sodium on Microvascular Health
EXPERIMENTALCross over design with a baseline and 4 dietary interventions
Interventions
Diet contains 1,500 mg sodium per day Diet does not contain dairy cheese 8 days
Diet contains 1,500 mg sodium per day Diet contains 6 oz dairy cheese per day 8 days
Diet contains 5,500 mg sodium per day Diet does not contain dairy cheese 8 days
Diet contains 5,500 mg sodium per day Diet contains 6 oz dairy cheese per day 8 days
Eligibility Criteria
You may qualify if:
- Seated systolic pressure 120-140 mmHg
- Seated diastolic pressure 70-90 mmHg.
- Normoglycemic (HbA1C \<5.7%)
You may not qualify if:
- Taking pharmacotherapy that alters peripheral vascular control
- Pregnancy
- Breastfeeding
- Females taking contraceptives (pills, patches, shots, etc.) or hormone replacement therapy
- Taking illicit and/or recreational drugs
- Use of nicotine containing-products (e.g. smoking, chewing tobacco, etc.)
- Known allergy to latex or investigative substances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lacy Alexanderlead
- National Dairy Councilcollaborator
Study Sites (1)
Pennsylvania State University
University Park, Pennsylvania, 16802, United States
Related Publications (1)
Alba BK, Stanhewicz AE, Dey P, Bruno RS, Kenney WL, Alexander LM. Controlled Feeding of an 8-d, High-Dairy Cheese Diet Prevents Sodium-Induced Endothelial Dysfunction in the Cutaneous Microcirculation of Healthy, Older Adults through Reductions in Superoxide. J Nutr. 2020 Jan 1;150(1):55-63. doi: 10.1093/jn/nxz205.
PMID: 31504721DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Professor Lacy Alexander
- Organization
- Penn State University
Study Officials
- PRINCIPAL INVESTIGATOR
Lacy M Alexander, PhD
Penn State University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Investigator and Outcomes Assessor are masked according to treatment.
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Kinesiology
Study Record Dates
First Submitted
December 13, 2017
First Posted
December 18, 2017
Study Start
July 1, 2017
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
May 4, 2025
Results First Posted
May 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share